Independent report

Use of the AstraZeneca COVID-19 vaccine: JCVI statement

Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.

Documents

Details

Statement from the Joint Committee on Vaccination and Immunisation (JCVI) following reports of an extremely rare adverse event after vaccination with the first dose of the AstraZeneca COVID-19 vaccine.

Updates to this page

Published 7 April 2021

Sign up for emails or print this page